Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $9.34M in the twelve months ending March 31, 2025, up 28.12% year-over-year. In the year 2024, Janux Therapeutics had annual revenue of $10.59M with 30.99% growth.

• Revenue (ttm): $9.34M
• Revenue Growth: +28.12%
• P/S Ratio: 158.93
• Revenue / Employee: $115,259
• Employees: 81
• Market Cap: 1.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.59M	2.51M	30.99%
Dec 31, 2023	8.08M	-529.00K	-6.14%
Dec 31, 2022	8.61M	4.98M	136.79%
Dec 31, 2021	3.64M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.